Mylan to buy marketing rights to MS treatment from Israel's Mapi Pharma - Reuters

Mylan to buy marketing rights to MS treatment from Israel's Mapi Pharma - Reuters | marketing - Google News | April 10, 2018 at 09:07AM

Mylan to buy marketing rights to MS treatment from Israel's Mapi Pharma Reuters (Reuters) - Drugmaker Mylan NV is acquiring global marketing rights to an experimental multiple sclerosis treatment from Israel's Mapi Pharma Ltd, the companies said on Tuesday. Both companies will partner on the development and commercialization of GA ...

April 10, 2018 at 09:07AM | marketing - Google News
Mylan to buy marketing rights to MS treatment from Israel's Mapi Pharma - Reuters
marketing - Google News